February 24, 2021By Mel J. YeatesBlending datasets for better researchAI collaboration seeks to improve access to COVID-19 datasets across institutions
February 24, 2021By Mel J. YeatesDeveloping antibodies against SARS-CoV-2DIOS-202 and DIOS-203 have been engineered for high potency and potential for avoiding escape mutants
Infectious Disease & VaccinesFebruary 22, 2021By Mel J. YeatesA COVID-19 home testing team-upBD has partnered with Scanwell Health for an at-home rapid test for COVID-19
Tools & Techniques NewsFebruary 11, 2021By DDN StaffTurning to AI for COVID prognosesBiodesix publishes paper detailing the use of its AI-based algorithm to identify COVID-19 patients who are likely to need medical intervention
Infectious Disease & VaccinesFebruary 9, 2021By DDN StaffDeveloping a COVID-19 skin testIntradermal test is designed to measure SARS-CoV-2-specific delayed type hypersensitivity
Infectious Disease & VaccinesFebruary 9, 2021By DDN StaffJohnson & Johnson submits EUA for COVID-19 vaccineJohnson & Johnson applies to FDA for an EUA for its single-shot Janssen COVID-19 vaccine candidate
Infectious Disease & VaccinesJanuary 29, 2021By DDN StaffNVX-CoV2373 achieves notable efficacy in Phase 3 trialNovavax’s NVX-CoV2373 first to demonstrate clinical efficacy against the UK and South Africa variants of COVID-19
Clinical ResearchJanuary 28, 2021By DDN StaffOff to a good startInitial data from Regeneron's Phase 3 trial of REGEN-COV show that the passive vaccine reduces COVID-19 infections and viral shedding
Infectious Disease & VaccinesJanuary 28, 2021By DDN StaffA 'Mammoth' boost to COVID-19 testing capacityMammoth Biosciences and Agilent team up to launch an automated solution for SARS-CoV-2 testing
Infectious Disease & VaccinesJanuary 28, 2021By Mel J. YeatesHeparin can target SARS-CoV-2 spike proteinThe anticoagulant drug could be repurposed for COVID-19 treatment